| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 0 | 39.290 | 26.343 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 0 | 39.430 | 28.296 |
| Total Expenses - EUR | - | - | - | - | - | 2 | 2 | 111 | 8.619 | 10.264 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -2 | -2 | -111 | 30.811 | 18.032 |
| Net Profit/Loss - EUR | - | - | - | - | - | -2 | -2 | -111 | 30.484 | 17.225 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Implanterix Doc Halliday S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 41 | 36 | 34 | 38.764 | 32.468 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 2.173 | 13.675 |
| Cash | - | - | - | - | - | 41 | 36 | 34 | 2.223 | 3.716 |
| Shareholders Funds | - | - | - | - | - | 39 | 36 | -74 | 30.410 | 17.274 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2 | 0 | 109 | 8.354 | 15.195 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Implanterix Doc Halliday S.r.l.